Thrombosis research gives patients access to ‘cutting edge’ care
With four clinical trials underway and the groundwork being laid for a fifth, Niagara Health has positioned itself as a leader in thrombosis research.
Share This Page
With four clinical trials underway and the groundwork being laid for a fifth, Niagara Health has positioned itself as a leader in thrombosis research.
Physicians, staff, students and community members doing research or quality improvement work to support a healthier Niagara are invited to showcase their work with a poster presentation at the upcoming Niagara Health Research Day on Thursday, May 4 at Brock University.
A Niagara Health intensivist’s efforts to grow a national community hospital research network continue to gain momentum while raising the profile of research at Niagara Health.
Findings show that both medical masks and N95 respirators work equally well in protecting against the respiratory virus.
Dr. Eric Nguyen compiled the largest body of data yet to help radiation oncologists make more informed decisions about using stereotactic body radiation therapy to treat lung and bone cancers that have metastasized.
Findings will help cancer doctors better treat recurring prostate cancer in those choosing a non-standard approach as first-line treatment.
Dr. Mohammad Refaei’s efforts to help his colleagues make the most informed decisions about administering blood transfusions have earned Niagara Health national recognition.
More than 110 researchers across Niagara and Hamilton participated in Niagara Health’s second Annual Research Day.
Researchers across Niagara and Hamilton will be gathering virtually for Niagara Health’s second Annual Research Day to share their findings and ideas to improve overall health and well-being, patient outcomes and the way care is delivered in our communities and beyond.
Niagara Health’s second Annual Research Day will take place virtually on Thursday, April 28, 2022 from 9 a.m. to 12:45 p.m.